Most just lately, it's been identified that conolidine and the above derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in very similar places as classical opioid receptors, it binds to some big selection of endogenous opioids. Compared with most opioid receptors, this receptor acts for a scavenger and won't activate a s